Associated tags: NYSE, Action, Security (finance), Private investigator, Online gambling, AL, DO, Class Action, NOT, Court order, Ontario Superior Court of Justice, Justice, TSX, Class, Person, New York justice courts, Securities Class Action, CP, Aphria
Locations: QUEBEC, CANADA
Plaintiff,
Binge eating,
Schizophrenia,
Risk,
Failure,
Defendant,
Research,
Class,
Compulsive buying disorder,
Superior court,
James Gamble (industrialist),
Hypersexuality,
Person The Plaintiffs alleged that REXULTI® causes Compulsive Behaviours and Impulse Control Disorders, including compulsive gambling, hypersexuality, compulsive shopping, and binge eating, and that the Defendants, Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc., failed to warn the Class Members and their physicians of this risk.
Key Points:
- The Plaintiffs alleged that REXULTI® causes Compulsive Behaviours and Impulse Control Disorders, including compulsive gambling, hypersexuality, compulsive shopping, and binge eating, and that the Defendants, Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc., failed to warn the Class Members and their physicians of this risk.
- The Defendants deny these allegations, and the Superior Court has not yet ruled on the merits of the class action.
- If you wish to remain in the action, you do not need to take any further action.
- To learn more about your rights, contact Class Counsel or visit their website at: https://www.rochongenova.com/current-class-action-cases/rexulti/
NYSE,
Ontario Superior Court of Justice,
CP,
Securities Class Action,
Time,
New York justice courts,
Person,
Class,
TSX,
Justice,
Court order,
Action,
NOT,
Class Action,
DO,
AL,
Online gambling,
Private investigator,
Security (finance),
Aphria The Ontario Superior Court of Justice has granted leave pursuant to the Ontario Securities Act and has certified a global securities class action which permits a defined group of investors (the "Class") to pursue claims againstAphria Inc. and certain of its Officers and Directors ("Aphria Defendants").
Key Points:
- The Ontario Superior Court of Justice has granted leave pursuant to the Ontario Securities Act and has certified a global securities class action which permits a defined group of investors (the "Class") to pursue claims againstAphria Inc. and certain of its Officers and Directors ("Aphria Defendants").
- The certified class action is Vecchio Longo Consulting Services Inc. v. Aphria Inc. et al.
- The allegations made in the Class Action have not been proven and are disputed bythe Aphria Defendants.
- As a Class Member, you will not be required to pay any costs in the event that the Class Action is unsuccessful.
Prospectus,
Defendant,
Ontario,
Person,
Time,
Ontario Superior Court of Justice,
Court,
Motion,
Justice,
Lists of schools in England,
Holding company,
Insurance TORONTO, Aug. 10, 2021 /PRNewswire/ - On August 6, 2021, the Ontario Superior Court of Justice granted the plaintiff in Vecchio Longo Consulting Services Inc. v. Aphria Inc. et.
Key Points:
- TORONTO, Aug. 10, 2021 /PRNewswire/ - On August 6, 2021, the Ontario Superior Court of Justice granted the plaintiff in Vecchio Longo Consulting Services Inc. v. Aphria Inc. et.
- CV-19-00614086-00CP) (the "Action") leave to proceed, with a global securities class action for misrepresentations pursuant to section 138.3 of the Ontario Securities Act against Aphria Inc. and its former officers and directors Victor Neufeld and Cole Cacciavillani (the "Aphria Defendants").
- In the same decision, the Court certified this secondary market shareholder claim as a class proceeding (the "Secondary Market Claim"), and appointed Vecchio Longo Consulting Services Inc. as representative plaintiff.
- The Class Period is defined as "the period of time after 07:00 ET January 29, 2018 until 08:25 ET December 3, 2018."
Retrieved on:
Friday, February 12, 2021
TORONTO and MONTREAL, Feb. 12, 2021 /PRNewswire/ -Class actions have been commenced on behalf ofall Canadian owners and/or lessees of 2017-2020 Model Year Chrysler Pacifica Plug-In Hybrid vehicles affected by a dangerous electrical system defect which can cause spontaneous and catastrophic fires.
Key Points:
- TORONTO and MONTREAL, Feb. 12, 2021 /PRNewswire/ -Class actions have been commenced on behalf ofall Canadian owners and/or lessees of 2017-2020 Model Year Chrysler Pacifica Plug-In Hybrid vehicles affected by a dangerous electrical system defect which can cause spontaneous and catastrophic fires.
- Each plaintiff suffered the catastrophic loss of their Chrysler Pacific Plug-In Hybrid minivan during a spontaneous fire.
- The Plaintiffs allege that these fires were caused by a dangerous defect in the electrical system of their vehicles.
- The recall documentation noted that the vehicles were affected by a dangerous electrical system defect which can cause spontaneous fires without warning, whether the vehicle is on or off.
In a 310-page decision delivered after 53 days of trial evidence and submissions, Justice Morgan held that Ontario and the psychiatrists involved in operating the experimental programs breached their fiduciary duties and committed assault and battery by subjecting these patients to unethical and medically meritless programs.
Key Points:
- In a 310-page decision delivered after 53 days of trial evidence and submissions, Justice Morgan held that Ontario and the psychiatrists involved in operating the experimental programs breached their fiduciary duties and committed assault and battery by subjecting these patients to unethical and medically meritless programs.
- Participation in the programs was a "condition for gaining freedom" from the maximum-security institution, withdrawal was prohibited and non-participation was punished, often at the hands of other patients.
- The Defendants' experts, including Dr. Stephen Hucker,conceded in cross-examination that the programs were unprecedented, unethical, and inhumane.
- Jonathan Freedman, admitted that the Plaintiffs should never have been subjected to these programs.
Civil law,
Economy,
Service industries,
Finance,
Civil procedure,
Medtronic,
Settlement,
Disbursement,
Insurance,
Class action,
Lawsuit TORONTO, April 1, 2020 /CNW/ - The Ontario Superior Court of Justice has approved a settlement in a Canadian class action lawsuit related to certain ICD Leads manufactured by Medtronic, Inc. and/or Medtronic of Canada Ltd.
Key Points:
- TORONTO, April 1, 2020 /CNW/ - The Ontario Superior Court of Justice has approved a settlement in a Canadian class action lawsuit related to certain ICD Leads manufactured by Medtronic, Inc. and/or Medtronic of Canada Ltd.
- The Settlement provides for the creation of a $26 million CDN settlement fund which will be used to pay compensation to eligible Class Members, payments to public health insurers, as well as administration costs and court-approved legal fees and disbursements.
- The Settlement is not an admission of liability on the part of the defendants, nor has there been any finding of liability by the Court against them.
- represent the Class Members.
Civil law,
Economy,
Service industries,
Finance,
Civil procedure,
Medtronic,
Settlement,
Disbursement,
Class action,
Insurance,
Lawsuit TORONTO, April 1, 2020 /CNW/ -The Ontario Superior Court of Justice has approved a settlement in a Canadian class action lawsuit related to certain defibrillators manufactured before December 31, 2003 by Medtronic, Inc. and/or Medtronic of Canada Ltd.
Key Points:
- TORONTO, April 1, 2020 /CNW/ -The Ontario Superior Court of Justice has approved a settlement in a Canadian class action lawsuit related to certain defibrillators manufactured before December 31, 2003 by Medtronic, Inc. and/or Medtronic of Canada Ltd.
- The Settlement provides for the creation of a $3.072 million CDN settlement fund which will be used to pay compensation to eligible Class Members, payments to public health insurers, as well as administration costs and court-approved legal fees and disbursements.
- The Settlement is not an admission of liability on the part of the defendants, nor has there been any finding of liability by the Court against them.
- represent the Class Members.
Retrieved on:
Wednesday, August 14, 2019
TORONTO, Aug. 14, 2019 /PRNewswire/ - THORNTON GROUT FINNIGAN LLP AND ROCHON GENOVA LLP have together commenced a class action in Ontario on behalf of shareholders of CannTrust Holdings Inc. (TSX: TRST, NYSE: CTST) who acquired their CannTrust common shares between October 1, 2018 up to and including July 8, 2019.
Key Points:
- TORONTO, Aug. 14, 2019 /PRNewswire/ - THORNTON GROUT FINNIGAN LLP AND ROCHON GENOVA LLP have together commenced a class action in Ontario on behalf of shareholders of CannTrust Holdings Inc. (TSX: TRST, NYSE: CTST) who acquired their CannTrust common shares between October 1, 2018 up to and including July 8, 2019.
- The class action seeks damages from CannTrust, certain of its officers and directors, and its auditors KPMG, arising out of alleged misrepresentations in CannTrust's required public disclosure, including its 2018 audited annual financial statements.
- Joel P. Rochon, Managing Partner at Rochon Genova, said: "Accurate and timely public disclosure is the lifeblood of our capital markets.
- For further information please contact: Gail Oxtoby at [email protected] or Ron Podolny at [email protected]
View original content to download multimedia: http://www.prnewswire.com/news-releases/thornton-grout-finnigan-llp-and-...
TORONTO, May 23, 2019 /PRNewswire/ - Today, the law firms of Rochon Genova LLP and Thomson Rogers issued aclass action on behalf of Canadians who were implanted with breast implants manufactured and distributed by Allergan plc and several of its affiliates.
Key Points:
- TORONTO, May 23, 2019 /PRNewswire/ - Today, the law firms of Rochon Genova LLP and Thomson Rogers issued aclass action on behalf of Canadians who were implanted with breast implants manufactured and distributed by Allergan plc and several of its affiliates.
- She is anxious to have her implants surgically removed soon in order to alleviate her symptoms and to hopefully mitigate her risk of developing BIA-ALCL.
- There needs to be accountability for these companies when they place profit ahead of patient safety."
- The allegations raised in the claim have not yet been proven in court.The plaintiffs and the prospective class members are represented by the Toronto based law firms of Rochon Genova LLP and Thomson Rogers.
TORONTO, Feb. 8, 2019 /PRNewswire/ - ROCHON GENOVA LLP has commenced a class action in Ontario on behalf of shareholders of Aphria Inc. (TSX: APHA, NYSE: APHA) who acquired their Aphria securities between January 29, 2018 up to and including November 30, 2018.
Key Points:
- TORONTO, Feb. 8, 2019 /PRNewswire/ - ROCHON GENOVA LLP has commenced a class action in Ontario on behalf of shareholders of Aphria Inc. (TSX: APHA, NYSE: APHA) who acquired their Aphria securities between January 29, 2018 up to and including November 30, 2018.
- The class action seeks damages from Aphria and others arising out of alleged misrepresentations in Aphria's required public disclosure.
- The alleged misrepresentations relate to Aphria's disclosure to the market regarding its acquisition of assets and entities involved in the cannabis industry in several jurisdictions.
- Joel P. Rochon, Managing Partner at Rochon Genova, said: "Accurate and timely public disclosure is the lifeblood of our capital markets.
